Crossmark

A comparison of FLAG-Ida and daunorubicin combined with clofarabine in high-risk acute myeloid leukaemia: data from the UK NCRI AML17 Trial

Crossref DOI link: https://doi.org/10.1038/s41375-018-0148-3

Published Online: 2018-06-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Burnett, A K

Hills, R K

Nielsen, O J

Freeman, S

Ali, A

Cahalin, P

Hunter, A

Thomas, I F

Russell, N H
License Information

Text and Data Mining valid from 2018-06-06
More Information

Article History

Received: 26 September 2017

Revised: 24 January 2018

Accepted: 1 February 2018

First Online: 6 June 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.